Pharmacovigilance of esketamine nasal spray: an analysis of the FDA adverse event reporting system database

• 主要な著者: Ruixue Liu (著者), Chunxiao Liu (著者), Dianwei Feng (著者), Tongxin Guo (著者), Ying Wang (著者)
• フォーマット: 図書
• 出版事項: Frontiers Media S.A., 2024-06-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Esketamine nasal spray (ESK-NS) is a new drug for treatment-resistant depression, and we aimed to detect and characterize the adverse events (AEs) of ESK-NS using the Food and Drug Administration (FDA) adverse event reporting system (FAERS) database between 2019 Q1 and 2023 Q4. Reporting odds ratio...